AU3765500A - 50 human secreted proteins - Google Patents

50 human secreted proteins

Info

Publication number: AU3765500A
Authority: AU; Australia
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1999-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU37655/00A

Other languages

English (en)

Inventor

George Komatsoulis

Craig A Rosen

Steven M. Ruben

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-26

Filing date

2000-03-22

Publication date

2000-10-16

2000-03-22 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2000-10-16 Publication of AU3765500A publication Critical patent/AU3765500A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Immunology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Transplantation (AREA)
Obesity (AREA)
Toxicology (AREA)
Zoology (AREA)

AU37655/00A 1999-03-26 2000-03-22 50 human secreted proteins Abandoned AU3765500A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US12650399P	1999-03-26	1999-03-26
US60126503		1999-03-26
US17240999P	1999-12-17	1999-12-17
US60172409		1999-12-17
PCT/US2000/007440 WO2000058339A2 (fr)	1999-03-26	2000-03-22	50 proteines humaines secretees

Publications (1)

Publication Number	Publication Date
AU3765500A true AU3765500A (en)	2000-10-16

Family

ID=26824730

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU37655/00A Abandoned AU3765500A (en)	1999-03-26	2000-03-22	50 human secreted proteins

Country Status (5)

Country	Link
EP (1)	EP1220947A2 (fr)
JP (1)	JP2003535570A (fr)
AU (1)	AU3765500A (fr)
CA (1)	CA2368281A1 (fr)
WO (1)	WO2000058339A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1847550A3 (fr) *	2001-07-19	2008-01-09	Nymox Corporation	Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules
EP1417227B1 (fr) *	2001-07-19	2007-01-10	Nymox Corporation	Peptides efficaces dans le traitement de tumeurs et d'autres etats pathologiques necessitant l'ablation ou la destruction de cellules
US7317077B2 (en)	2001-11-16	2008-01-08	Nymox Pharmaceutical Corporation	Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
AU2006339072A1 (en)	2005-03-14	2007-10-25	Board Of Regents Of The University Of Texas System	Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
US11628202B2 (en)	2015-07-24	2023-04-18	Nymox Corporation	Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en)	2016-06-17	2019-01-22	Nymox Corporation	Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en)	2016-07-28	2019-01-08	Nymox Corporation	Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en)	2016-09-07	2020-01-14	Nymox Corporation	Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en)	2017-03-01	2019-07-02	Nymox Corporation	Compositions and methods for improving sexual function

2000
- 2000-03-22 AU AU37655/00A patent/AU3765500A/en not_active Abandoned
- 2000-03-22 EP EP00916566A patent/EP1220947A2/fr not_active Withdrawn
- 2000-03-22 CA CA002368281A patent/CA2368281A1/fr not_active Abandoned
- 2000-03-22 WO PCT/US2000/007440 patent/WO2000058339A2/fr active Search and Examination
- 2000-03-22 JP JP2000608039A patent/JP2003535570A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2000058339A3 (fr)	2002-05-10
EP1220947A2 (fr)	2002-07-10
WO2000058339A2 (fr)	2000-10-05
JP2003535570A (ja)	2003-12-02
CA2368281A1 (fr)	2000-10-05

Publication	Publication Date	Title
AU1473501A (en)	2001-06-06	21 human secreted proteins
AU1438001A (en)	2001-05-14	27 human secreted proteins
AU1604401A (en)	2001-05-30	18 human secreted proteins
AU1448701A (en)	2001-06-06	15 human secreted proteins
AU1334101A (en)	2001-05-14	19 human secreted proteins
AU3769700A (en)	2000-10-16	45 human secreted proteins
AU2757500A (en)	2000-08-29	33 human secreted proteins
AU6745700A (en)	2000-11-02	49 human secreted proteins
AU1918601A (en)	2001-05-30	23 human secreted proteins
AU3517000A (en)	2000-10-04	50 human secreted proteins
AU1916101A (en)	2001-06-06	19 human secreted proteins
AU3628600A (en)	2000-10-09	46 human secreted proteins
AU1342501A (en)	2001-05-14	32 human secreted proteins
AU3765500A (en)	2000-10-16	50 human secreted proteins
AU3249300A (en)	2000-10-04	47 human secreted proteins
AU3396600A (en)	2000-10-04	49 human secreted proteins
AU3208700A (en)	2000-08-07	33 human secreted proteins
AU1449001A (en)	2001-06-06	28 human secreted proteins
AU1472801A (en)	2001-06-06	24 human secreted proteins
AU3766800A (en)	2000-10-16	48 human secreted proteins
AU3628700A (en)	2000-10-09	49 human secreted proteins
AU3767300A (en)	2000-10-16	47 human secreted proteins
AU3730500A (en)	2000-10-09	50 human secreted proteins
AU3747000A (en)	2000-10-09	49 human secreted proteins
AU1438201A (en)	2001-05-14	25 human secreted proteins

Legal Events

Date	Code	Title	Description
2002-03-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase